NIAGEN BIOSCIENCE, INC.: accounts_receivable
| Value | {"amount": 5234000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2023-12-31) |
| Status | current |
| Entity | NIAGEN BIOSCIENCE, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:23:06.494871+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/81cf01e8-d7f6-4275-94f8-8b2d59a9a728
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-24-021645Retrieved: 2026-08-19T13:23:06.494871+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001386570/accounts-receivable/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/81cf01e8-d7f6-4275-94f8-8b2d59a9a728
History
- no predecessors — first report